ProjectGMMG-DANTE
Basic data
Title:
GMMG-DANTE
Duration:
01/12/2016 to 30/11/2020
Abstract / short description:
A phase 2, open-label, multicentric trial. Daratumumab in combination with Bortezomib and Dexamethasone in subjects with relapsed and refractory Multiple Myeloma and severe renal impairment including subjects undergoing hemodialysis.
Keywords:
Multiple Myeloma
Involved staff
Managers
Weisel, Katja
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Neuss, Nordrhein-Westfalen, Germany